Journal of Medicinal Chemistry · 2018 · 51 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyComputational Medicinal ChemistryDrug DesignDrug DiscoveryDe Novo Drug DesignLigand BindingLigand-based DesignNatural Product Drug DiscoveryNatural Product-based Drug DesignReceptor ModelingComputational Natural Product DesignLigand Design For ReceptorsLigand-based De Novo DesignModulator DesignModulator SelectivityNatural Product FunctionalizationStructure-activity Relationship Guided DesignStructure-based Ligand Design
Natural products (NPs) are progressively recognized as invaluable source of pharmacological tools and lead structures. To enable NP-inspired retinoid X receptor (RXR) modulator design, three novel RXR-targeting NPs were computationally identified. Among them, valerenic acid was found to be selective for RXRβ, rendering it a unique pharmacological tool compound. The NPs then served as templates for automated, ligand-based de novo design of innovative, easily accessible mimetics that inherited the biological activities of their natural templates.
15
Retinoid X receptor gamma signaling accelerates CNS remyelination
Jeffrey K. Huang, Andrew A. Jarjour, Brahim Nait‐Oumesmar et al. · Nature Neuroscience · 2010 · 549 citations · Full text
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Markus Hartenfeller, Heiko Zettl, Miriam Walter et al. · PLoS Computational Biology · 2012 · 264 citations · Full text
De Novo Design at the Edge of Chaos
Petra Schneider, Gisbert Schneider · Journal of Medicinal Chemistry · 2016 · 168 citations · Full text